Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

[1]  T. Klein,et al.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network , 2011, Clinical pharmacology and therapeutics.

[2]  R. Altman,et al.  Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. , 2010, The Lancet. Oncology.

[3]  J. Berg,et al.  Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come , 2010, Journal of Clinical Pathology.

[4]  W. Newman,et al.  Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications? , 2010, Pharmacogenomics.

[5]  K. Schmiegelow,et al.  Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia , 2010, Leukemia.

[6]  R. Baldassano,et al.  Variation in Care in Pediatric Crohn Disease , 2009, Journal of pediatric gastroenterology and nutrition.

[7]  R. Weinshilboum,et al.  Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study , 2009, Leukemia.

[8]  J. Gisbert,et al.  Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain , 2009, European Journal of Human Genetics.

[9]  M. Relling,et al.  Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia , 2009, Clinical pharmacology and therapeutics.

[10]  I. Bruce,et al.  Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription , 2007, Journal of clinical pharmacy and therapeutics.

[11]  N. Reynolds,et al.  Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial , 2006, The Lancet.

[12]  M. Relling,et al.  Thiopurine methyltransferase in acute lymphoblastic leukemia. , 2006, Blood.

[13]  C. Pui,et al.  The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005 , 2005, Leukemia.

[14]  N. Reynolds,et al.  Guidelines for prescribing azathioprine in dermatology , 2004, The British journal of dermatology.

[15]  Michel Eichelbaum,et al.  Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. , 2004, Pharmacogenetics.

[16]  K. Schmiegelow,et al.  Methylated Metabolites of 6‐mercaptopurine are Associated with Hepatotoxicity , 2004, Clinical pharmacology and therapeutics.

[17]  W. Evans.  Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy , 2004, Therapeutic drug monitoring.

[18]  W. Sandborn.  Pharmacogenomics and IBD: TPMT and Thiopurines , 2004, Inflammatory bowel diseases.

[19]  Igor Walukiewicz,et al.  Games for synthesis of controllers with partial observation , 2003, Theor. Comput. Sci..

[20]  R. Weinshilboum.  Inheritance and drug response. , 2003, The New England journal of medicine.

[21]  E. Louis,et al.  Safe treatment of thiopurine S-methyltransferase deficient Crohn’s disease patients with azathioprine , 2003, Gut.

[22]  P. S. Thiagarajan,et al.  A Decidable Class of Asynchronous Distributed Controllers , 2002, CONCUR.

[23]  M. Eichelbaum,et al.  Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. , 2002, Pharmacogenetics.

[24]  S. Tripakis,et al.  Undecidable problems of decentralized observation and control , 2001, Proceedings of the 40th IEEE Conference on Decision and Control (Cat. No.01CH37228).

[25]  O. Kupermann,et al.  Synthesizing distributed systems , 2001, Proceedings 16th Annual IEEE Symposium on Logic in Computer Science.

[26]  M. Relling,et al.  Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. G. Thistle,et al.  Effective control synthesis for DES under partial observations , 2000, Proceedings of the 39th IEEE Conference on Decision and Control (Cat. No.00CH37187).

[28]  R. Weinshilboum,et al.  Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency. , 2000, Journal of pediatric hematology/oncology.

[29]  M. Relling,et al.  Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. , 1999, Journal of the National Cancer Institute.

[30]  H. McLeod,et al.  Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine , 1998, Annals of Internal Medicine.

[31]  L. Lennard.  Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions. , 1998, Therapeutic drug monitoring.

[32]  W. Evans,et al.  Pharmacogenetics of cancer therapy: getting personal. , 1998, American journal of human genetics.

[33]  Thomas A. Henzinger,et al.  Alternating-time temporal logic , 1997, Proceedings 38th Annual Symposium on Foundations of Computer Science.

[34]  Ching-Hon Pui,et al.  Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance , 1997, Annals of Internal Medicine.

[35]  J. Lilleyman,et al.  Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism. , 1996, Therapeutic drug monitoring.

[36]  Ronald Fagin.  Reasoning about knowledge , 1995 .

[37]  Ken Jones,et al.  Getting Personal , 1995 .

[38]  P. Morris.  Introduction to Game Theory , 1994 .

[39]  W. Evans,et al.  Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. , 1991, The Journal of pediatrics.

[40]  E. Allen Emerson,et al.  Tree automata, mu-calculus and determinacy , 1991, [1991] Proceedings 32nd Annual Symposium of Foundations of Computer Science.

[41]  W. Murray Wonham,et al.  Think Globally, Act Locally: Decentralized Supervisory Control , 1991, 1991 American Control Conference.

[42]  W. M. Wonham,et al.  Decentralized control and coordination of discrete-event systems with partial observation , 1990 .

[43]  Amir Pnueli,et al.  Distributed reactive systems are hard to synthesize , 1990, Proceedings [1990] 31st Annual Symposium on Foundations of Computer Science.

[44]  R. Weinshilboum,et al.  Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia , 1990, The Lancet.

[45]  W. M. Wonham,et al.  The control of discrete event systems , 1989, Proc. IEEE.

[46]  R. Weinshilboum,et al.  Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism , 1989, Clinical pharmacology and therapeutics.

[47]  Amir Pnueli,et al.  On the synthesis of a reactive module , 1989, POPL '89.

[48]  Joseph Y. Halpern.  A little knowledge goes a long way: simple knowledge-based derivations and correctness proofs for a family of protocols , 1987, PODC '87.

[49]  Ronald Fagin,et al.  A formal model of knowledge, action, and communication in distributed systems: preliminary report , 1985, PODC '85.

[50]  S. Gillen.  Getting personal. , 2012, Mental health today.

[51]  J. Cho,et al.  Rational Dosing of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Diseases , 2003 .

[52]  P. Madhusudan,et al.  Control and synthesis of open reactive systems , 2001 .

[53]  Marc Pauly,et al.  Logic for social software , 2000 .

[54]  Wojciech Penczek,et al.  Local Interactions, Explicit Communication and Causal Knowledge in Games and Multi-Agent Systems , 1999, CEEMAS.

[55]  Hagit Attiya,et al.  Distributed Computing: Fundamentals, Simulations and Advanced Topics , 1998 .

[56]  A. Rubinstein,et al.  A Course in Game Theory , 1994 .